Plasma cell leukemia (PCL) is a rare disease that may ... lenalidomide and transplant-based regimens will probably improve treatment outcome. There is insufficient information to support ...

For many decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. But, in recent years, a newer therapy in the form of immunotherapy has emerged, ...

Thanks to new treatments, people with refractory multiple myeloma have more options and may live longer. In multiple myeloma, abnormal plasma cells multiply in your bone marrow — the soft ...

Rahul Banerjee is a physician-researcher who specializes in multiple myeloma, a blood cancer caused by plasma cells that can cause bone and kidney ... the experiences of patients as they undergo ...